Intervention Review

You have free access to this content

Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child

  1. Michael S Kramer1,*,
  2. Ritsuko Kakuma2

Editorial Group: Cochrane Pregnancy and Childbirth Group

Published Online: 12 SEP 2012

Assessed as up-to-date: 23 JUL 2012

DOI: 10.1002/14651858.CD000133.pub3


How to Cite

Kramer MS, Kakuma R. Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD000133. DOI: 10.1002/14651858.CD000133.pub3.

Author Information

  1. 1

    McGill University Faculty of Medicine, Departments of Pediatrics and Epidemiology, Biostatistics and Occupational Health, Montreal, Quebec, Canada

  2. 2

    The University of Melbourne, Centre for International Mental Health, Melbourne School of Population Health, Carlton, Victoria, Australia

*Michael S Kramer, Departments of Pediatrics and Epidemiology, Biostatistics and Occupational Health, McGill University Faculty of Medicine, 2300 Tupper Street, Les Tourelles, Montreal, Quebec, H3H 1P3, Canada. michael.kramer@mcgill.ca.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 12 SEP 2012

SEARCH

[Analysis 1.1]
Analysis 1.1. Comparison 1 Maternal antigen avoidance in pregnancy in women at high risk for atopic offspring, Outcome 1 Atopic eczema in first 12-18 months.
[Analysis 1.2]
Analysis 1.2. Comparison 1 Maternal antigen avoidance in pregnancy in women at high risk for atopic offspring, Outcome 2 Asthma in first 18 months.
[Analysis 1.3]
Analysis 1.3. Comparison 1 Maternal antigen avoidance in pregnancy in women at high risk for atopic offspring, Outcome 3 Allergic rhinitis/conjunctivitis in first 18 months.
[Analysis 1.4]
Analysis 1.4. Comparison 1 Maternal antigen avoidance in pregnancy in women at high risk for atopic offspring, Outcome 4 Allergic urticaria in first 18 months.
[Analysis 1.5]
Analysis 1.5. Comparison 1 Maternal antigen avoidance in pregnancy in women at high risk for atopic offspring, Outcome 5 Any atopic condition in first 18 months.
[Analysis 1.6]
Analysis 1.6. Comparison 1 Maternal antigen avoidance in pregnancy in women at high risk for atopic offspring, Outcome 6 Positive skin prick test to egg at 6 months.
[Analysis 1.7]
Analysis 1.7. Comparison 1 Maternal antigen avoidance in pregnancy in women at high risk for atopic offspring, Outcome 7 Positive skin prick test to egg at 18 months.
[Analysis 1.8]
Analysis 1.8. Comparison 1 Maternal antigen avoidance in pregnancy in women at high risk for atopic offspring, Outcome 8 Positive skin prick test to milk at 6 months.
[Analysis 1.9]
Analysis 1.9. Comparison 1 Maternal antigen avoidance in pregnancy in women at high risk for atopic offspring, Outcome 9 Positive skin prick test to milk at 18 months.
[Analysis 1.10]
Analysis 1.10. Comparison 1 Maternal antigen avoidance in pregnancy in women at high risk for atopic offspring, Outcome 10 Detectable cord blood IgE (>= .125 U/ml).
[Analysis 1.11]
Analysis 1.11. Comparison 1 Maternal antigen avoidance in pregnancy in women at high risk for atopic offspring, Outcome 11 Cord blood IgE > 1 U/ml.
[Analysis 1.12]
Analysis 1.12. Comparison 1 Maternal antigen avoidance in pregnancy in women at high risk for atopic offspring, Outcome 12 Preterm birth.
[Analysis 1.13]
Analysis 1.13. Comparison 1 Maternal antigen avoidance in pregnancy in women at high risk for atopic offspring, Outcome 13 Gestational weight gain (as % of prepregnancy weight).
[Analysis 1.14]
Analysis 1.14. Comparison 1 Maternal antigen avoidance in pregnancy in women at high risk for atopic offspring, Outcome 14 Birthweight (g).
[Analysis 2.1]
Analysis 2.1. Comparison 2 Maternal antigen avoidance during lactation in women at high risk for atopic offspring, Outcome 1 Incidence of atopic eczema in first 18 months.
[Analysis 2.2]
Analysis 2.2. Comparison 2 Maternal antigen avoidance during lactation in women at high risk for atopic offspring, Outcome 2 Positive skin prick test to milk at 1 year.
[Analysis 2.3]
Analysis 2.3. Comparison 2 Maternal antigen avoidance during lactation in women at high risk for atopic offspring, Outcome 3 Positive skin prick test to egg at 1 year.
[Analysis 2.4]
Analysis 2.4. Comparison 2 Maternal antigen avoidance during lactation in women at high risk for atopic offspring, Outcome 4 Positive skin prick test to peanut at 1 year.
[Analysis 2.5]
Analysis 2.5. Comparison 2 Maternal antigen avoidance during lactation in women at high risk for atopic offspring, Outcome 5 Positive skin prick test to milk at 2 years.
[Analysis 2.6]
Analysis 2.6. Comparison 2 Maternal antigen avoidance during lactation in women at high risk for atopic offspring, Outcome 6 Positive skin prick test to egg at 2 years.
[Analysis 2.7]
Analysis 2.7. Comparison 2 Maternal antigen avoidance during lactation in women at high risk for atopic offspring, Outcome 7 Positive skin prick test to peanut at 2 years.
[Analysis 2.8]
Analysis 2.8. Comparison 2 Maternal antigen avoidance during lactation in women at high risk for atopic offspring, Outcome 8 Positive skin prick test to milk at 7 years.
[Analysis 2.9]
Analysis 2.9. Comparison 2 Maternal antigen avoidance during lactation in women at high risk for atopic offspring, Outcome 9 Positive skin prick test to egg at 7 years.
[Analysis 2.10]
Analysis 2.10. Comparison 2 Maternal antigen avoidance during lactation in women at high risk for atopic offspring, Outcome 10 Positive skin prick test to peanut at 7 years.
[Analysis 3.1]
Analysis 3.1. Comparison 3 Maternal antigen avoidance during lactation for treating atopic eczema in infants, Outcome 1 Eczema area score.
[Analysis 3.2]
Analysis 3.2. Comparison 3 Maternal antigen avoidance during lactation for treating atopic eczema in infants, Outcome 2 Eczema activity score.